Effectiveness and tolerability of cephalexin and clavulanic acid fixed dose combination, amoxicillin and clavulanic acid fixed dose combination, and azithromycin in patients with pharyngitis in India: a real-world retrospective study from electronic medical records (PHARYSPOR) - Takeaways - MDSpire

Effectiveness and tolerability of cephalexin and clavulanic acid fixed dose combination, amoxicillin and clavulanic acid fixed dose combination, and azithromycin in patients with pharyngitis in India: a real-world retrospective study from electronic medical records (PHARYSPOR)

  • By

  • Subramanyam Sarof

  • Nikita Kariappa Somana

  • Ravindra Channagiri S

  • Ramesh Chinthalapalli Venkataram

  • Jyothi Sharma R

  • Sabhapathi SV

  • Ramakrishnaiah Peddi

  • Sadanandam K

  • Nitin Rai Vohra

  • Lokesh Kumar Bhama

  • Mahendrakumar Shah

  • Vijay Chile

  • Ameeta Gunderia

  • Farad Momin

  • Anit Banerjee

  • Saumitra Kumar

  • Sandeep Rungta

  • Ashik Ikbal

  • Sunil Singhvi

  • Annamalai Natarajan

  • Monjori Mitra

  • Vijay Kadam

  • Shruti Dharmadhikari

  • Chintan Khandhedia

  • Gaurav Puppalwar

  • Neeraj Markandeywar

  • Amey Mane

  • Suyog Mehta

  • July 9, 2026

  • 0 min

Share

  • 1

    The study assessed the effectiveness of cephalexin-clavulanate compared to co-amoxiclav and azithromycin for treating acute bacterial pharyngitis.

  • 2

    Clinical cure rates by Day 10 were similar across cephalexin-CV, co-amoxiclav, and azithromycin treatment groups.

  • 3

    Cephalexin-CV showed earlier clinical improvement by Day 2 and Day 3 compared to co-amoxiclav and azithromycin.

  • 4

    The requirement for NSAIDs was lower in the cephalexin-CV group compared to the azithromycin group.

  • 5

    Adverse events were minimal across all treatment groups, with mild gastritis reported in the cephalexin-CV group.

Original Source(s)

Effectiveness and tolerability of cephalexin and clavulanic acid fixed dose combination, amoxicillin and clavulanic acid fixed dose combination, and azithromycin in patients with pharyngitis in India: a real-world retrospective study from electronic medical records (PHARYSPOR)

  • by Subramanyam Sarof, Nikita Kariappa Somana, Ravindra Channagiri S, Ramesh Chinthalapalli Venkataram, Jyothi Sharma R, Sabhapathi SV, Ramakrishnaiah Peddi, Sadanandam K, Nitin Rai Vohra, Lokesh Kumar Bhama, Mahendrakumar Shah, Vijay Chile, Ameeta Gunderia, Farad Momin, Anit Banerjee, Saumitra Kumar, Sandeep Rungta, Ashik Ikbal, Sunil Singhvi, Annamalai Natarajan, Monjori Mitra, Vijay Kadam, Shruti Dharmadhikari, Chintan Khandhedia, Gaurav Puppalwar, Neeraj Markandeywar, Amey Mane, Suyog Mehta

  • July 9, 2026

Related Content

Hemoglobin glycation index and short-term mortality in sepsis: a retrospective cohort study with external validation

Targeted lipid metabolism screening uncovers regulatory effects on the STING immune response in mevalonate, eicosanoid and fatty acid pathways

Alanine aminotransferase elevation in hospitalized children with infectious mononucleosis: independent associations with Epstein–Barr virus DNA load, age, and sex